KM7-61913-18804
4 vaccinations
3 coded responses
28 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 537 / WI
- Registered
- 2021-09-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
AMH-82458-17883
Child or adolescent in my care · Male · 2022-06-23
Timeline
-
2021-04-09
Dose 1 — Pfizer-BioNTech
-
2021-04-30
Dose 2 — Pfizer-BioNTech
-
2021-09-26
Registered in v-safe
- 2021-10-30
-
2021-11-05
Dose 3 — Pfizer-BioNTech
- 2021-11-05
- 2021-11-06
- 2021-11-07
- 2021-11-08
- 2021-11-09
- 2021-11-11
- 2021-11-12
- 2021-11-19
- 2021-11-26
- 2021-12-03
-
2021-12-10
Survey response — day 35, dose 3MedDRA: Neuralgia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Lumbar nerve painMedDRA releases: 2024-11 · check-in free text available
-
2021-12-10
Report sent to call center — day 35, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · 1 call case(s)
-
2021-12-15
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2021-12-17
- 2022-02-04
- 2022-05-06
-
2022-09-08
Dose 4 — Pfizer-BioNTech
- 2022-09-08
-
2022-09-09
Survey response — days 1–6 daily, dose 4MedDRA: Oropharyngeal pain, Respiratory tract congestion — Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches · Be unable to do your normal daily activitiesFree text: Sore throat and congestionMedDRA releases: 2024-11 · check-in free text available
- 2022-09-10
- 2022-09-12
- 2022-09-14
- 2022-09-17
- 2022-09-22
- 2022-09-29
- 2022-10-06
- 2022-10-13
- 2022-10-20
- 2022-12-08
-
2023-03-09
Survey response — 6 months, dose 4MedDRA: Alanine aminotransferase increased, Aspartate aminotransferase increased — Feeling: Good · Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationMedDRA releases: 2024-11
-
2023-03-09
Report sent to call center — 6 months, dose 4Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2023-03-10
-
2023-03-15
Callback requested for04:00PM ET
-
2023-03-15
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-09 | Pfizer-BioNTech | No |
| 2 | 2021-04-30 | Pfizer-BioNTech | No |
| 3 | 2021-11-05 | Pfizer-BioNTech | No |
| 4 | 2022-09-08 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 successful
Free text
Release 10 — day 35, dose 3
Symptoms: Lumbar nerve pain
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Sore throat and congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Alanine aminotransferase increased | · | · | ✓ |
| SD | Aspartate aminotransferase increased | · | · | ✓ |
| SD | Neuralgia | · | · | ✓ |
| SRO | Oropharyngeal pain | · | · | ✓ |
| SRO | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release